Share This

Related Topics News -

     
 Title only   |   Print    Next page > 
     
宜明昂科IMC-003/IMM72臨床試驗申請獲受理

2025-04-02T  
宜明昂科董事長兼CEO增持15萬股 涉79萬元

2025-03-27T  
《業績》宜明昂科全年虧損收窄至3.16億人民幣

2025-03-26T  
宜明昂科-B收到H股全流通備案通知書

2025-03-17T  
宜明昂科治療腫瘤藥物獲內地批准進行臨床試驗

2025-03-06T  
《大行》中金料27隻股份可能符合納入「港股通」條件 包括華潤飲料等

2025-02-24T  
宜明昂科IMM2510聯合化療臨床試驗完成首例患者給藥

2025-01-13T  
宜明昂科出售上海工業地 變現9,819萬人民幣

2024-12-30T  
宜明昂科IMM0306的IB期臨床試驗完成首例患者給藥

2024-12-18T  
宜明昂科治療狼瘡性腎炎藥獲國家藥監局批准臨床試驗

2024-12-02T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.